News

News and analysis from Seiden Law on complex litigation, sanctions and regulatory enforcement, and cross-border recovery.

The Seiden Law Announces U.S. Shareholders Formation Of A Group To Recover Investor Funds Through A Possible Receivership Over China-Based Huifeng Bio-Pharmaceutical Technology, Inc (Ticker_ HFGB)

Huifeng Bio-Pharmaceutical Technology, Inc. (Ticker: HFGB), is a British Virgin Islands corporation involved in the business of manufacturing and marketing pharmaceutical raw materials and ingredients, such as pharmaceuticals…

March 21, 2017 1 min read